2nd Joint Meeting « Hepatocyte User Group & Medicon Valley Hepatocyte User Forum »
Friday 22 October 2010
8:00-8:30 |
Registration |
---|---|
8:30-8:40 |
Welcome and introduction Patrick Maurel |
---|---|
8:40 |
Session 1: |
---|---|
Hepatocyte from Stem Cell: where are we, where do we go? |
|
Chairman: Patrick Maurel | |
8:40-9:10 | Cell reprogramming: extreme cell plasticity |
John De Vos, Inserm Montpellier - France | |
9:10-9:40 | Embryonic and induced pluripotent stem cell derived hepatocytes... |
Nicholas Hannan, University of Cambridge - UK | |
9:40-10:30 | Coffee break - Visit of exhibition - Posters |
10:30-11:00 | Comparative analysis of hepatocyte-like cells generated from liver progenitor cells and human embryonic stem cells |
Martine Daujat-Chavanieu, Inserm Montpellier - France | |
11:00-11:30 | Hepatic maturation of human fetal hepatocytes in four-compartment 3D perfusion culture |
Toshio Miki, Rangos Research Center, Pittsburgh PA - USA | |
11:30-12:45 |
Oral communications |
Chairman: Martin Bayliss |
|
11:30-11:45 | Maintenance of hepatic phenotype and function in novel human 3D tissue cultures from reconstituted primary fetal liver tissues |
Cliff Rowe et al., University of Manchester - UK | |
11:45-12:00 | The hepatotrophic growth factor augmenter of liver regeneration (ALR) protects human hepatocytes against induced apoptosis by up-regulation of survival pathways |
Maren Ilowski et al., University of Munich, Munich - Germany | |
12:00-12:15 | System-dependent inhibition of cytochrome P450 (CYP) enzymes |
David B. Buckley et al,. XenoTech LLC, Lenexa KS - USA | |
12:15-12:30 | Optimization of thawing, culture, treatment and enzyme activity determination of cryopreserved human hepatocytes (cryoheps) for their use in the ECVAM international validation study of cytochrome P450 induction |
Alexandre E, et al., KaLy Cell, Strasbourg - France | |
12:30-12:45 | Comparison of different processing times, temperatures and storage methods on RNA stability in human liver |
Serene M.L. Lee et al., University of Munich, Munich - Germany | |
12:45-14:30 |
Lunch - Visit of exhibition - Posters |
14:30 |
Session 2: |
miRNAs and siRNAs: Regulating gene expression in hepatocytes |
|
Chairman: Gabrielle Hawksworth | |
14:30-15:00 | siRNAs to delineate roles of nuclear receptors in induction of Oatps in primary cultures of hepatocytes |
Gabrielle Hawksworth, University of Aberdeen - UK | |
15:00-15:30 | Micro RNA signatures in phenobarbital-induced liver toxicity |
Nigel Gooderham, Imperial College, London - UK | |
15:30-16:00 | Coffee break - Visit of exhibition - Posters |
16:00-16:30 | AAV-mediated knock-down of apolipoprotein B100 in vivo using SHRNA |
Pavlina Konstantinova, AMT Biopharma, Amsterdam - The Netherlands | |
16:30-17:00 | From plastic to patient: Identifying the barriers to therapeutic oligo delivery |
Steve Hood, GOLD team, PCD DMPK, GSK R&D, Ware - UK | |
17:00-19:00 |
Posters session - Wine & Beer Cocktail |
19:15 |
Bus departure for Conference dinner |